Study on Treatment of Chronic Fatigue with MSC-CM

JRCT ID: jRCT1051240143

Registered date:02/10/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Chronic Fatigue
• Date of first enrollment: 02/10/2024
• Study type: Observational

Outcome(s)

Primary Outcome

1. atigue Visual Analogue Scale (VAS)
2.Chalder Fatigue Scale

• Secondary Outcome: subjective symptoms, etc.

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1. Those who have not achieved satisfactory therapeutic effects with standard treatments.
2. Those who do not wish to use existing medications due to concerns about side effects and are deemed suitable for treatment with culture supernatant by their physician..

The patient selection criteria are as follows:
<Inclusion Criteria>
Patients meeting the following criteria will be considered eligible:

1. Individuals aged 18 and above.
2. Individuals with normal decision-making capacity.
3. Individuals who have been provided with the informed consent document regarding this treatment, received sufficient explanation, and can provide voluntary written consent.
4. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclude criteria

Exclusion Criteria
Anyone who meets any of the following conditions will be excluded:
1. Users of narcotics or stimulants.
2. Those deemed unsuitable by the attending physician.

Related Information

• Primary Sponsor: Atsutomo Morishima